From Name:
From Email:
To Name:
To Email:

Optional Message:


Why we're in a 'different era' of cancer research, and where things go from here

from GeekWire

Four decades ago, the overall chance of someone surviving cancer was about 50-50 — not exactly a promising outlook. Today, those numbers have dramatically increased as new drugs and cancer-fighting biotechnologies make their way from labs into hospitals around the world. “It’s an extraordinary time,” said Robert Hershberg, a longtime scientist and biotech executive who is now an executive vice president and head of business development at Celgene. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063